Gene · 5699
Papers1,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oncolytic Adenovirus, a New Treatment Strategy for Prostate Cancer. | Biomedicines | 2022 | 36552019 | PubTator, text mining | PubMed |
| Immune landscape-based machine-learning-assisted subclassification, prognosis, and immunotherapy prediction for glioblastoma. | Front Immunol | 2022 | 36532035 | PubTator, text mining | PubMed |
| Intranasal inoculation of IFN-λ resolves SARS-CoV-2 lung infection via the rapid reduction of viral burden and improvement of tissue damage. | Front Immunol | 2022 | 36524125 | PubTator, text mining | PubMed |
| Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockade. | NPJ Precis Oncol | 2022 | 36522538 | PubTator, text mining | PubMed |
| Nasal administration of anti-CD3 monoclonal antibody modulates effector CD8+ T cell function and induces a regulatory response in T cells in human subjects. | Front Immunol | 2022 | 36505477 | PubTator, text mining | PubMed |
| A Novel Mechanism of Immunoproteasome Regulation via miR-369-3p in Intestinal Inflammatory Response. | Int J Mol Sci | 2022 | 36430249 | PubTator, text mining | PubMed |
| The Impact of Deleting Stem-Loop 1 of Epstein-Barr Virus-Encoded RNA 1 on Cell Proliferation. | Viruses | 2022 | 36423146 | PubTator, text mining | PubMed |
| Interferon partly dictates a divergent transcriptional response in poxvirus-infected and bystander inflammatory monocytes. | Cell Rep | 2022 | 36417857 | PubTator, text mining | PubMed |
| State Mindful Attention Awareness as a Dyadic Protective Factor During COVID-19: a Daily Diary Study. | Mindfulness (N Y) | 2022 | 36408117 | PubTator, text mining | PubMed |
| Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments. | Front Immunol | 2022 | 36389823 | PubTator, text mining | PubMed |
| Glia as antigen-presenting cells in the central nervous system. | Curr Opin Neurobiol | 2022 | 36371828 | PubTator, text mining | PubMed |
| Genes associated with diagnosis and prognosis of Burkitt lymphoma. | IET Syst Biol | 2022 | 36354023 | PubTator, text mining | PubMed |
| Chemotherapy induces ACE2 expression in breast cancer via the ROS-AKT-HIF-1α signaling pathway: a potential prognostic marker for breast cancer patients receiving chemotherapy. | J Transl Med | 2022 | 36335375 | PubTator, text mining | PubMed |
| A novel amino acid metabolism-related gene risk signature for predicting prognosis in clear cell renal cell carcinoma. | Front Oncol | 2022 | 36313638 | PubTator, text mining | PubMed |
| Ubiquitin Proteasome Gene Signatures in Ependymoma Molecular Subtypes. | Int J Mol Sci | 2022 | 36293188 | PubTator, text mining | PubMed |
| Mapping human disease-associated enzymes into Reactome allows characterization of disease groups and their interactions. | Sci Rep | 2022 | 36289281 | PubTator, text mining | PubMed |
| The type 1 diabetes gene TYK2 regulates β-cell development and its responses to interferon-α. | Nat Commun | 2022 | 36289205 | PubTator, text mining | PubMed |
| Meta-analysis of active tuberculosis gene expression ascertains host directed drug targets. | Front Cell Infect Microbiol | 2022 | 36275035 | PubTator, text mining | PubMed |
| Trio-based whole exome sequencing in patients with suspected sporadic inborn errors of immunity: A retrospective cohort study. | Elife | 2022 | 36250618 | PubTator, text mining | PubMed |
| Transcriptional states of CAR-T infusion relate to neurotoxicity - lessons from high-resolution single-cell SOM expression portraying. | Front Immunol | 2022 | 36248848 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5699/papers?page=11